La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Takeda Pharmaceutical Gestion
Gestion contrôle des critères 2/4
Takeda Pharmaceutical's CEO is Christophe Weber, appointed in Jun 2014, has a tenure of 10.17 years. total yearly compensation is ¥2.08B, comprised of 15.2% salary and 84.8% bonuses, including company stock and options. directly owns 0.05% of the company’s shares, worth ¥3.43B. The average tenure of the management team and the board of directors is 6.9 years and 8.2 years respectively.
Informations clés
Christophe Weber
Directeur général
JP¥2.1b
Rémunération totale
Pourcentage du salaire du PDG | 15.2% |
Durée du mandat du directeur général | 10.2yrs |
Propriété du PDG | 0.05% |
Durée moyenne d'occupation des postes de direction | 6.9yrs |
Durée moyenne du mandat des membres du conseil d'administration | 8.2yrs |
Mises à jour récentes de la gestion
Recent updates
Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's
Aug 08Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 02Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00
Jul 25Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's
Jul 11Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year
Jun 30Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt
Jun 11Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings
May 21Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next
May 12Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00
Mar 28Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00
Mar 13Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00
Feb 26Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Jun 30 2024 | n/a | n/a | JP¥150b |
Mar 31 2024 | JP¥2b | JP¥317m | JP¥144b |
Dec 31 2023 | n/a | n/a | JP¥178b |
Sep 30 2023 | n/a | n/a | JP¥192b |
Jun 30 2023 | n/a | n/a | JP¥301b |
Mar 31 2023 | JP¥2b | JP¥295m | JP¥317b |
Dec 31 2022 | n/a | n/a | JP¥275b |
Sep 30 2022 | n/a | n/a | JP¥213b |
Jun 30 2022 | n/a | n/a | JP¥197b |
Mar 31 2022 | JP¥2b | JP¥281m | JP¥230b |
Dec 31 2021 | n/a | n/a | JP¥439b |
Sep 30 2021 | n/a | n/a | JP¥473b |
Jun 30 2021 | n/a | n/a | JP¥431b |
Mar 31 2021 | JP¥2b | JP¥267m | JP¥376b |
Dec 31 2020 | n/a | n/a | JP¥181b |
Sep 30 2020 | n/a | n/a | JP¥56b |
Jun 30 2020 | n/a | n/a | JP¥120b |
Mar 31 2020 | JP¥2b | JP¥273m | JP¥44b |
Dec 31 2019 | n/a | n/a | JP¥13b |
Sep 30 2019 | n/a | n/a | JP¥83b |
Jun 30 2019 | n/a | n/a | JP¥64b |
Mar 31 2019 | JP¥2b | JP¥269m | JP¥135b |
Dec 31 2018 | n/a | n/a | JP¥110b |
Sep 30 2018 | n/a | n/a | JP¥141b |
Jun 30 2018 | n/a | n/a | JP¥120b |
Mar 31 2018 | JP¥1b | JP¥254m | JP¥187b |
Rémunération vs marché: Christophe's total compensation ($USD14.22M) is above average for companies of similar size in the JP market ($USD1.64M).
Rémunération et revenus: Christophe's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
PDG
Christophe Weber (58 yo)
10.2yrs
Titularisation
JP¥2,083,000,000
Compensation
Mr. Christophe Weber has been the President and Chief Executive Officer of Takeda Pharmaceutical Company Limited since June 27, 2014 and April 2015 respectively and served as its Chief Operating Officer fr...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
President | 10.2yrs | JP¥2.08b | 0.050% ¥ 3.4b | |
Chair of Management Board | no data | pas de données | pas de données | |
CFO & Director | less than a year | pas de données | 0.00083% ¥ 57.4m | |
Member of Management Board | no data | pas de données | pas de données | |
Member of Management Board and Head of R&D Global Science & Biomedical Policy | no data | pas de données | pas de données | |
Chief Accounting Officer & Corporate Controller | no data | pas de données | pas de données | |
Senior Vice President of Corporate Finance & Controlling Department | 11.4yrs | pas de données | pas de données | |
Chief Data & Technology Officer | 2.5yrs | pas de données | pas de données | |
Global Head of Investor Relations & Global Finance | 3.9yrs | pas de données | pas de données | |
Global General Counsel | 9.8yrs | pas de données | pas de données | |
Chief Ethics & Compliance Officer | 9.8yrs | pas de données | pas de données | |
Chief Human Resources Officer | 3.6yrs | pas de données | pas de données |
6.9yrs
Durée moyenne de l'emploi
51.5yo
Âge moyen
Gestion expérimentée: 4502's management team is seasoned and experienced (6.9 years average tenure).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
President | 10.2yrs | JP¥2.08b | 0.050% ¥ 3.4b | |
CFO & Director | no data | pas de données | 0.00083% ¥ 57.4m | |
President of Research & Development and Representative Director | 9.2yrs | JP¥972.00m | 0.0087% ¥ 603.8m | |
Independent External Director | 2.2yrs | JP¥32.00m | pas de données | |
Independent External Director | 5.6yrs | JP¥44.00m | 0.00026% ¥ 18.0m | |
Independent External Director | 8.2yrs | JP¥49.00m | 0.00016% ¥ 11.1m | |
Independent External Director | 8.2yrs | JP¥40.00m | 0.00079% ¥ 54.6m | |
Independent External Director | 5.6yrs | JP¥44.00m | 0.000070% ¥ 4.8m | |
Independent External Director | 5.2yrs | JP¥38.00m | pas de données | |
Independent External Director | 8.2yrs | JP¥46.00m | pas de données | |
Independent External Chair | 3.2yrs | JP¥43.00m | 0.000020% ¥ 1.4m | |
Independent External Director | 8.2yrs | JP¥43.00m | 0.00063% ¥ 43.6m |
8.2yrs
Durée moyenne de l'emploi
66.5yo
Âge moyen
Conseil d'administration expérimenté: 4502's board of directors are considered experienced (8.2 years average tenure).